✦ LIBER ✦

Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines

✍ Scribed by Newall, A. T.; Jit, M.; Hutubessy, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human papillomavirus vaccine introductio

✍ Mark Jit; Nadia Demarteau; Elamin Elbasha; Gary Ginsberg; Jane Kim; Naiyana Prad 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 364 KB

Cost effective interventions for the pre

✍ Amir Shroufi, Rajiv Chowdhury, Raghupathy Anchala, Sarah Stevens… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 296 KB

Active pharmaceutical management strateg

✍ Laura Faden; Catherine Vialle-Valentin; Dennis Ross-Degnan; Anita Wagner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Using workshops to develop theories of c

✍ Breuer, Erica; De Silva, Mary J; Fekadu, Abebaw; Luitel, Nagendra; Murhar, Vaibh 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 645 KB

CE2 Cost-Effectiveness of the Real-World

✍ Wu, G.H.M.; Wang, Y.C.; Lin, S.J.; Lin, K.S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB